EUNUVY Trademark

Trademark Overview


On Friday, July 1, 2022, a trademark application was filed for EUNUVY with the United States Patent and Trademark Office. The USPTO has given the EUNUVY trademark a serial number of 97485013. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, November 20, 2024. This trademark is owned by Sage Therapeutics, Inc.. The EUNUVY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of epilepsy, essential tremors, Parkinson's disease, epileptiform disorders, Huntington's disease, Alzheimer's, dementia, GABA hypofunction, and NMDA hypofunction; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
eunuvy

General Information


Serial Number97485013
Word MarkEUNUVY
Filing DateFriday, July 1, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, November 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of epilepsy, essential tremors, Parkinson's disease, epileptiform disorders, Huntington's disease, Alzheimer's, dementia, GABA hypofunction, and NMDA hypofunction; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSage Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, July 5, 2022NEW APPLICATION ENTERED
Thursday, July 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 3, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 5, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, April 5, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, July 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 14, 2023SUSPENSION LETTER WRITTEN
Friday, July 14, 2023LETTER OF SUSPENSION E-MAILED
Friday, July 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 11, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 20, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED